コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ferentiation, epithelial cell phenotypes and fibroblast proliferation.
2 ibrosis-related genes in addition to cardiac fibroblast proliferation.
3 has revealed a dose-dependent inhibition of fibroblast proliferation.
4 Polymerized type I collagen suppresses fibroblast proliferation.
5 guanosine monophosphate and inhibits cardiac fibroblast proliferation.
6 by IL-1beta-stimulated fibroblasts enhances fibroblast proliferation.
7 bserved that miR-125b inhibits p53 to induce fibroblast proliferation.
8 sical and novel PKC isozymes does not affect fibroblast proliferation.
9 The C-terminal domain of CTGF mediates fibroblast proliferation.
10 ght-driven H2O2 production and inhibition of fibroblast proliferation.
11 ith P-15 did not have any effect on gingival fibroblast proliferation.
12 d untreated root shavings inhibited gingival fibroblast proliferation.
13 gated the inhibitory effects of IFN-gamma on fibroblast proliferation.
14 rface had synergistic effects in stimulating fibroblast proliferation.
15 produced interferon 1 (IFN1), which inhibits fibroblast proliferation.
16 side synthesis blocked growth factor-induced fibroblast proliferation.
17 ectively bypass the requirement for c-myc in fibroblast proliferation.
18 as a downstream mediator of TGF-beta-induced fibroblast proliferation.
19 th fibroblast-bearing coils showed extensive fibroblast proliferation.
20 iated with osteoclastogenesis inhibition and fibroblast proliferation.
21 important to their synergistic effects on BM fibroblast proliferation.
22 and in synergy with either cytokine induced fibroblast proliferation.
23 tant to elucidate factors regulating cardiac fibroblast proliferation.
24 iac fibroblast-derived) adenosine on cardiac fibroblast proliferation.
25 of endogenous NO synthesis had no effect on fibroblast proliferation.
26 ophy and/or remodeling by modulating cardiac fibroblast proliferation.
27 1c+ CD11b+ CD1c- phagolysosome+) upon dermal fibroblast proliferation.
28 eta resulted in decreased CD11b- dermal cell fibroblast proliferation.
29 omeostatic restraint of primary human dermal fibroblast proliferation.
30 ed Ca(2+) entry, ERK1/2 phosphorylation, and fibroblast proliferation.
31 tion of endothelial cells, and more synovial fibroblast proliferation.
32 emonstrate central roles for LPA and LPA1 in fibroblast proliferation.
33 on indicating the essential role of STAT3 in fibroblast proliferation.
34 harmacological inhibitor of aneuploid murine fibroblast proliferation.
35 eir activation and subsequent stimulation of fibroblast proliferation.
36 atory cell adhesion and migration as well as fibroblast proliferation.
37 dent CTGF expression, which, in turn, drives fibroblast proliferation.
38 ulating Sprouty-1, a protein that suppresses fibroblast proliferation.
39 ed kinase phosphorylation inhibition reduced fibroblast proliferation.
40 bilical vein endothelial cell monolayers and fibroblast proliferation.
41 HAS3 knockdown by shRNA caused inhibition of fibroblast proliferation.
42 hairpin RNA [shRNA]) decreased canine atrial fibroblast proliferation.
43 f dominant-negative FoxO3a augmented control fibroblast proliferation.
44 enced by its enhancement of keratinocyte and fibroblast proliferation.
45 asses of gadolinium chelates stimulate human fibroblast proliferation.
46 her confirmed that histamine inhibited heart fibroblast proliferation.
47 activator (tPA) promotes renal interstitial fibroblast proliferation.
48 a phosphorylation, cyclin D1 expression, and fibroblast proliferation.
49 y synergistically inhibits FoxO3a, promoting fibroblast proliferation.
50 n, proliferation-related gene induction, and fibroblast proliferation.
51 a1 integrin signaling prevented tPA-mediated fibroblast proliferation.
52 ll-conditioned media or coculture stimulated fibroblast proliferation, activation, and myofibroblast
54 brosis (IPF) is characterized by exaggerated fibroblast proliferation and accumulation of collagens a
55 vere endoluminal coronary injury resulted in fibroblast proliferation and adventitial remodeling.
58 ole, the same pathway surprisingly inhibited fibroblast proliferation and cardiac hypertrophy through
59 Conversely, overexpression of FGF2 increased fibroblast proliferation and collagen deposition, accele
61 K1/2 (MAPKK), and ERK1/2, on CTGF-stimulated fibroblast proliferation and collagen gel contraction wa
62 ibrotic cytokine IL-4 interact in regulating fibroblast proliferation and collagen production, and, i
64 pharmacological inhibition of c-abl reverses fibroblast proliferation and collagen synthesis to wild-
68 at MB was more effective in stimulating skin fibroblast proliferation and delaying cellular senescenc
71 that in turn regulate underlying mesenchymal fibroblast proliferation and differentiation at least in
73 gehog pathway inhibition was assayed by lung fibroblast proliferation and differentiation with and wi
74 ys remodelling at least partly by increasing fibroblast proliferation and differentiation with result
78 reases epidermal growth factor (EGF)-induced fibroblast proliferation and enhances EGF receptor (EGFR
79 is is a progressive disease characterized by fibroblast proliferation and excess deposition of collag
80 educed the ability of TGF-beta1 to stimulate fibroblast proliferation and expression of alpha-smooth
82 redominant source of TGF-beta1, which drives fibroblast proliferation and extracellular matrix deposi
83 dministration suppressed AF while decreasing fibroblast proliferation and extracellular matrix gene e
84 activation of IL-6 trans signaling enhanced fibroblast proliferation and extracellular matrix protei
85 ed protein (LRP) in the regulation of kidney fibroblast proliferation and extracellular signal-regula
86 e pathological consequence of stress-induced fibroblast proliferation and fibroblast-to-myofibroblast
87 les for dermal Wnt signaling/beta-catenin in fibroblast proliferation and in the epidermal hair folli
89 t size, deletion of FGF2 resulted in reduced fibroblast proliferation and interstitial collagen depos
90 ognized function of vimentin in coordinating fibroblast proliferation and keratinocyte differentiatio
91 , IIGP, GTPI, IGTP, Ifi202A), stimulators of fibroblast proliferation and matrix synthesis (interleuk
92 tial fibrosis, which correlated with reduced fibroblast proliferation and matrix synthesis, after nep
93 jor collagen/laminin receptor that regulates fibroblast proliferation and mesangial cell migration an
94 le cell types to coordinate keratinocyte and fibroblast proliferation and migration for epidermal and
95 induced beta-catenin activation, stimulated fibroblast proliferation and migration, collagen gel con
97 negative effects mediated by PGE2 on tendon fibroblast proliferation and MMP production, which may l
98 TRPC3 blockade or Ca(2+) removal inhibited fibroblast proliferation and myofibroblast differentiati
99 t CTGF blockade suppressed TGF-beta1-induced fibroblast proliferation and myofibroblast differentiati
100 poptosis have been implicated in the rampant fibroblast proliferation and pannus formation characteri
101 n a critical role to FKN and its receptor in fibroblast proliferation and pannus formation in RA.
102 Normally, polymerized collagen suppresses fibroblast proliferation and serves as a physiological r
103 may be important for both mitogen-stimulated fibroblast proliferation and skeletal muscle cell differ
104 d regeneration after injury, and stimulating fibroblast proliferation and the production of FN and co
105 olysaccharide hyaluronan (HA) in influencing fibroblast proliferation and thereby affecting wound hea
106 y dermis, whereas S100A9 was shown to induce fibroblast proliferation and to enhance fibroblast CCN2
107 nonreceptor c-abl tyrosine kinase regulates fibroblast proliferation and, by this means, is a costim
108 and this effect may be due to suppression of fibroblast proliferation and/or suppression of matrix de
110 sive disorder characterized by inflammation, fibroblast proliferation, and accumulation of extracellu
111 Ac-SDKP on monocyte/macrophage infiltration, fibroblast proliferation, and collagen deposition in the
114 rdiac remodeling which involves hypertrophy, fibroblast proliferation, and extracellular matrix produ
116 ed in post-infarct heart, stimulates cardiac fibroblast proliferation, and is induced by the proinfla
118 f the diarthroidial joints, characterized by fibroblast proliferation, angiogenesis, and perivascular
119 ration-dependent manner, FCS-induced cardiac fibroblast proliferation as assessed by DNA synthesis ([
121 ay also have deleterious effects on gingival fibroblast proliferation as well as collagen and non-col
122 ine the effects of chlorhexidine on gingival fibroblast proliferation as well as collagen and non-col
123 acid and gadolinium trichloride) stimulated fibroblast proliferation at a concentration of 0.01 mmol
124 meglumine) produced a maximum stimulation of fibroblast proliferation at a concentration of 0.1 mmol/
125 doteridol) produced a maximum stimulation of fibroblast proliferation at a concentration of 5 mmol/L.
126 monstrate that PGE2 can stimulate or inhibit fibroblast proliferation at clinically relevant concentr
127 etween P2 and P50 there was no difference in fibroblast proliferation at the wound site but Wnt signa
129 reduced Ang II-induced VSMC and adventitial fibroblast proliferation but had no effect on myoendothe
130 reated IL-5(-/-) mice were able to stimulate fibroblast proliferation but not alpha-smooth muscle act
131 rom KGF-treated subjects inhibited pulmonary fibroblast proliferation, but increased alveolar epithel
132 ast growth factors, all strong activators of fibroblast proliferation, but not by epidermal growth fa
133 onstrate that polymerized collagen represses fibroblast proliferation by a mechanism involving the fo
134 lagen suppresses G(1)/S phase transition and fibroblast proliferation by a novel mechanism involving
136 l 20 amino acids of caveolin-1 in modulating fibroblast proliferation by dampening Smad signaling and
137 on with polymerized collagen inhibits normal fibroblast proliferation by suppression of the phosphoin
139 , and the inhibitive effects of histamine on fibroblast proliferation could be blocked by JAK3/STAT6
140 d function of the skin secondary to impaired fibroblast proliferation, decreased collagen synthesis,
141 d function of the skin secondary to impaired fibroblast proliferation, decreased collagen synthesis,
143 are present in renal fibroblasts and control fibroblast proliferation, differentiation, and activatio
144 brought much attention to the regulation of fibroblast proliferation, differentiation, extracellular
145 g preparation enhanced IGF-stimulated 3T3-L1 fibroblast proliferation, due to the presence of a co-pu
146 echanical support of the ECM also stimulates fibroblast proliferation, expands vasculature, and incre
147 by PPM1A-depleted epithelial cells augmented fibroblast proliferation (>50%) compared with controls.
148 t size but were associated with unrestrained fibroblast proliferation, impaired scar remodeling, redu
151 activates ERK, and promotes inflammation and fibroblast proliferation in bleomycin-induced lung injur
153 rosis than wild-type mice due to 1) enhanced fibroblast proliferation in response to growth factors (
154 on induced by SV40 large T antigen supported fibroblast proliferation in the absence of betacyto-acti
157 We discovered that myostatin stimulated fibroblast proliferation in vitro and induced its differ
158 shown that angiotensin II induces human lung fibroblast proliferation in vitro via activation of the
159 of BAL fluid (BALF) to stimulate human lung fibroblast proliferation in vitro was examined in relati
160 r epidermal growth factor potentiated Nf1+/- fibroblast proliferation in vitro, demonstrating abnorma
165 3- and TUNEL-positive fibroblasts, decreased fibroblast proliferation, increased nuclear translocatio
169 Further studies revealed that the effect of fibroblast proliferation is biphasic, with the promitoge
172 pothesis that, in fibrotic gingival lesions, fibroblast proliferation is stimulated and apoptosis is
174 tPA as a mitogen that promotes interstitial fibroblast proliferation, leading to expansion of these
178 ocesses involved in wound healing, including fibroblast proliferation, migration, adhesion, and the a
179 wth factors significantly increased gingival fibroblast proliferation, migration, and cell adhesion o
183 for smooth muscle cells, myofibroblasts, and fibroblasts, proliferation of which is a hallmark of idi
186 ge in the presence of pulmonary neutrophils, fibroblast proliferation, or collagen gene expression.
187 and aFGF may contribute to angiogenesis and fibroblast proliferation, potentially independently of i
189 olymerized type I collagen normally inhibits fibroblast proliferation, providing a physiological mech
191 ata demonstrate that ATP-induced adventitial fibroblast proliferation requires activation and interac
192 expression of two genes that promote tendon fibroblast proliferation: scleraxis and tenomodulin.
193 embryonic lethality, neuronal apoptosis, and fibroblast proliferation/senescence defects but not lymp
194 the Chaos3 background and impaired embryonic fibroblast proliferation, suggesting that ATM drug inhib
195 ntin orchestrates the healing by controlling fibroblast proliferation, TGF-beta1-Slug signaling, coll
196 ma is associated with enhanced potential for fibroblast proliferation that is related, at least in pa
197 both Xenopus oocyte maturation and mammalian fibroblast proliferation, the underlying mechanisms resp
198 ated that TGF-beta1 inhibited murine cardiac fibroblast proliferation; these antiproliferative effect
200 a potent mitogen that promotes interstitial fibroblast proliferation through a cascade of signaling
201 l 20 amino acids of caveolin-1 in modulating fibroblast proliferation through dampening Smad signalin
203 ent mitogen that promotes renal interstitial fibroblast proliferation through LDL receptor-related pr
204 summary, HA facilitates TGF-beta1-dependent fibroblast proliferation through promoting interaction b
208 he relationship between c-myc expression and fibroblast proliferation using a c-myc antisense oligonu
209 ibroblast-derived adenosine inhibits cardiac fibroblast proliferation via activation of A2B receptors
216 ing intact Agtr1a) were infused with Ang II, fibroblast proliferation was found equally in these card
218 rol animals and demonstrated that peritoneal fibroblast proliferation was highly LPA1 dependent.
219 fibroblasts from an additional patient, and fibroblast proliferation was inhibited by BRAF-specific
221 was added to the medium (292 micrograms/ml) fibroblast proliferation was stimulated, and by 5-6 days
222 postmitotic cell proliferation and enhances fibroblast proliferation, whereas overexpressing miR-24
223 fibroblasts by inducing capillary growth and fibroblast proliferation, which secondarily support grea
224 d activation with interstitial inflammation, fibroblast proliferation with extracellular matrix colla
226 evious studies have implicated inhibition of fibroblast proliferation with polymerized collagen-media
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。